PHARMA EXECUTIVE CONSULTING LIMITED
LONDON

Hellopages » Greater London » Camden » WC1H 9BQ

Company number 07426392
Status Active
Incorporation Date 2 November 2010
Company Type Private Limited Company
Address LYNTON HOUSE, 7-12 TAVISTOCK SQUARE, LONDON, LONDON, WC1H 9BQ
Home Country United Kingdom
Nature of Business 82990 - Other business support service activities n.e.c.
Phone, email, etc

Since the company registration sixteen events have happened. The last three records are Confirmation statement made on 2 November 2016 with updates; Total exemption small company accounts made up to 30 November 2015; Annual return made up to 2 November 2015 with full list of shareholders Statement of capital on 2015-11-24 GBP 100 . The most likely internet sites of PHARMA EXECUTIVE CONSULTING LIMITED are www.pharmaexecutiveconsulting.co.uk, and www.pharma-executive-consulting.co.uk. The predicted number of employees is 1 to 10. The company’s age is fifteen years and one months. The distance to to Battersea Park Rail Station is 3.4 miles; to Brondesbury Park Rail Station is 3.7 miles; to Barnes Bridge Rail Station is 6.5 miles; to Beckenham Hill Rail Station is 8.5 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Pharma Executive Consulting Limited is a Private Limited Company. The company registration number is 07426392. Pharma Executive Consulting Limited has been working since 02 November 2010. The present status of the company is Active. The registered address of Pharma Executive Consulting Limited is Lynton House 7 12 Tavistock Square London London Wc1h 9bq. . LONNGREN, Thomas is a Director of the company. Director COWAN, Graham Michael has been resigned. The company operates in "Other business support service activities n.e.c.".


Current Directors

Director
LONNGREN, Thomas
Appointed Date: 10 November 2010
74 years old

Resigned Directors

Director
COWAN, Graham Michael
Resigned: 02 November 2010
Appointed Date: 02 November 2010
82 years old

Persons With Significant Control

Thomas Lonngren
Notified on: 6 April 2016
74 years old
Nature of control: Ownership of shares – 75% or more

PHARMA EXECUTIVE CONSULTING LIMITED Events

30 Nov 2016
Confirmation statement made on 2 November 2016 with updates
19 Aug 2016
Total exemption small company accounts made up to 30 November 2015
24 Nov 2015
Annual return made up to 2 November 2015 with full list of shareholders
Statement of capital on 2015-11-24
  • GBP 100

16 Sep 2015
Total exemption small company accounts made up to 30 November 2014
18 Nov 2014
Annual return made up to 2 November 2014 with full list of shareholders
Statement of capital on 2014-11-18
  • GBP 100

...
... and 6 more events
30 Oct 2012
First Gazette notice for compulsory strike-off
23 Nov 2011
Annual return made up to 2 November 2011 with full list of shareholders
15 Nov 2010
Appointment of Thomas Lonngren as a director
04 Nov 2010
Termination of appointment of Graham Cowan as a director
02 Nov 2010
Incorporation
  • MODEL ARTICLES ‐ Model articles adopted (Amended Provisions)